What is Specialty PharmaSource?
Specialty PharmaSource functions as a global partner for the pharmaceutical and biotechnology sectors, providing a comprehensive suite of services. Their core offerings include the sourcing of clinical supplies, manufacturing of sterile injectables, and expert consulting on regulatory compliance and the mitigation of drug shortages. By integrating U.S.-based regulatory acumen with an extensive international network, Specialty PharmaSource ensures the delivery of secure and reliable pharmaceutical solutions tailored to the needs of clinical research sponsors and drug development organizations.
How much funding has Specialty PharmaSource raised?
Specialty PharmaSource has raised a total of $49K across 1 funding round:
Debt
$49K
Debt (2021): $49K with participation from PPP
Key Investors in Specialty PharmaSource
PPP
Public-Private Partnership
What's next for Specialty PharmaSource?
With the recent influx of substantial expansion capital, Specialty PharmaSource is poised for accelerated growth and enhanced service delivery. The company's strategic focus on regulatory compliance and its established global sourcing capabilities suggest a trajectory aimed at solidifying its market position. Future developments are likely to involve scaling operations to meet increasing demand for comparator drugs and RLDs, potentially expanding its manufacturing capacity for sterile injectables, and further developing its consulting services to address complex regulatory landscapes and supply chain challenges within the pharmaceutical industry.
See full Specialty PharmaSource company page
